Home / Health / Common Antibiotic Linked to Higher Death Risk
Common Antibiotic Linked to Higher Death Risk
16 Sep
Summary
- Cefepime, an antibiotic, showed higher all-cause mortality in a global study.
- The study reviewed 110 trials with over 22,000 patients receiving cefepime.
- Researchers found a 94.4% probability of increased mortality with cefepime use.
A recent global study suggests that cefepime, a common antibiotic, may be associated with an increased risk of all-cause mortality. The research, published in JAMA Network Open, compiled data from 110 randomized clinical trials encompassing over 22,000 patients. These trials involved individuals treated for conditions such as pneumonia, urinary tract infections, and febrile neutropenia.
Across the analyzed trials, a meta-analysis revealed a 94.4% probability that cefepime was linked to higher mortality rates compared to other beta-lactam antibiotics. This association appeared more pronounced in adults and particularly in patients treated for febrile neutropenia, a serious medical emergency. The researchers did not recommend discontinuing cefepime but called for additional research to better understand its safety.
Potential explanations for the observed association include incorrect dosing, with both underdosing and overdosing possibly contributing to increased mortality risk. Experts emphasize the importance of re-evaluating drug safety data and suggest that precise dosing may be crucial. The study acknowledged limitations, including variations in trial design and patient populations, and noted that an association does not prove causation.
